AMBALAL SARABHAI ENTERPRISES
Back to All Ratios
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 30.05 | 37.66 | 11.07 | 5.40 | 4.26 |
What is the latest Price to Cash Earnings (PCE) ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 30.05 |
| Mar2024 | 37.66 |
| Mar2023 | 11.07 |
| Mar2022 | 5.40 |
| Mar2021 | 4.26 |
How is Price to Cash Earnings (PCE) of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 30.05 | -20.21 | |
| Mar2024 | 37.66 | 240.20 | |
| Mar2023 | 11.07 | 105.00 | |
| Mar2022 | 5.4 | 26.76 | |
| Mar2021 | 4.26 | - | |
Other Financial Ratios of AMBALAL SARABHAI ENTERPRISES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹201.2 Cr | -4.8% | -8.3% | -43.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -4.8% |
-8.3% |
-43.6% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses